Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells
about
"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus FormationSpecific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative SplicingIdentification of distant drug off-targets by direct superposition of binding pocket surfacesGenome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination.Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1.Tissue factor in tumor microenvironment: a systematic reviewDifferential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy.Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells.Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.Nonproteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models.Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non-Small Cell Lung Cancer Cell Lines.Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3pAlternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.PI3K inhibitors in cardiovascular disease.Regulation of vascular function on posttranscriptional level.The role of tissue factor isoforms in cancer biology.Integrated transcriptomic and metabolomic analysis reveals adaptive changes of hibernating retinas.Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP.
P2860
Q26786677-710BBE5B-FA99-4B92-928C-49E23645D524Q27666758-ED24742E-C31A-4613-A2B8-5BC242D08673Q28538129-F2DD0DEA-3D19-43A0-A6D1-AB4043815252Q30497476-82D4AD2C-9734-47BD-806E-CDE7F41BB28AQ33563951-AD61DCE7-DC32-4A7D-9943-9CE132578A0BQ33788023-F87D4BB9-1138-4815-B8ED-0AF26027ACABQ34544801-CAF5CFFE-9E4E-4CA6-8931-A9641C8145A7Q35143725-7BDC8D8F-9085-4D7B-9BFA-AB921A7F716FQ35534765-7723FAB9-C038-4837-A02A-58023B315644Q35797625-3F5B14A3-89F5-441F-8B7C-8ADDA7B29093Q36130930-85B6421C-C734-444F-94E4-8E31142713CDQ36349412-B1DD9BBB-D98E-458D-A567-FEB489B94064Q36447782-A2ECAB13-8D4B-4054-A928-6D54CB7303E9Q36876032-C25AC4DD-539B-4429-9945-2A43A090FC55Q37418686-BB2FFAE0-C79C-4398-95CA-0A3711CEA4A4Q37715189-AAB3678E-3DF2-4FFE-9481-AA92F79CB718Q37772192-08A64AD3-7818-4FAF-AC26-817FBDAB7726Q38167316-B3193090-3E8C-4B79-B45C-F543F519AA33Q38210094-F93AFABA-F029-4ECD-8ECD-1942C81BCD6EQ38764743-75D2FD62-78F9-4099-B96F-BEF4FC1FA88FQ54331313-26924345-8DAA-47BD-94AB-5A4A33DC6CBBQ54569298-CE3F1CA0-F9BC-48B6-B2FB-61C5AE369651
P2860
Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@ast
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en-gb
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@nl
type
label
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@ast
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en-gb
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@nl
prefLabel
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@ast
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en-gb
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@nl
P2093
P921
P1433
P1476
Cdc2-like kinases and DNA topo ...... tor in human endothelial cells
@en
P2093
Andreas Zakrzewicz
Axel Pries
Heinz-Peter Schultheiss
Silvio Antoniak
Ursula Rauch
Vladimir Y Bogdanov
Wolfgang Poller
P304
P356
10.1161/CIRCRESAHA.108.183905
P407
P577
2009-01-22T00:00:00Z